Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adrenal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03127774
What this trial is testing

Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma

Who this might be right for
Adrenocortical CarcinomaPeritoneal Carcinomatosis
Columbia University 30
Not applicableLooking for participantsNCT03221335
What this trial is testing

EUS-guided RFA for Solid Abdominal Neoplasms

Who this might be right for
Digestive System Neoplasms
Chinese University of Hong Kong 30
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Early research (Phase 1)Study completedNCT01898715
What this trial is testing

Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma

Who this might be right for
Adrenocortical CarcinomaAdrenal CancerACC
Millendo Therapeutics, Inc. 63
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Early research (Phase 1)Ended earlyNCT05999292
What this trial is testing

Phase 1 Study of 68Ga-R8760

Who this might be right for
Adrenocortical Carcinoma
Radionetics Oncology 11
Large-scale testing (Phase 3)UnknownNCT00002659
What this trial is testing

Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Matrix Pharmaceutical 120
Testing effectiveness (Phase 2)Study completedNCT01262235
What this trial is testing

A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients

Who this might be right for
CancerNeuroendocrine TumorsNET+2 more
Arbutus Biopharma Corporation 68
Testing effectiveness (Phase 2)Study completedNCT01514526
What this trial is testing

Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Spanish Oncology Genito-Urinary Group 17
Not applicableUnknownNCT04666220
What this trial is testing

VETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Carcinoma

Who this might be right for
Renal Cell CarcinomaAdrenal Carcinoma
Humanitas Clinical and Research Center 180
Testing effectiveness (Phase 2)Ended earlyNCT02720484
What this trial is testing

Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer

Who this might be right for
Metastatic Carcinoma in the Adrenal CortexRecurrent Adrenal Cortex CarcinomaStage III Adrenal Cortex Carcinoma+1 more
Northwestern University 10
Testing effectiveness (Phase 2)Study completedNCT00453895
What this trial is testing

Sunitinib in Refractory Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
University of Wuerzburg 39
Testing effectiveness (Phase 2)UnknownNCT04318730
What this trial is testing

Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
West China Hospital 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT02867592
What this trial is testing

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

Who this might be right for
Adrenal Cortical CarcinomaAlveolar Soft Part SarcomaCentral Nervous System Neoplasm+41 more
National Cancer Institute (NCI) 109
Early research (Phase 1)Looking for participantsNCT04897321
What this trial is testing

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

Who this might be right for
Pediatric Solid TumorOsteosarcomaRhabdomyosarcoma+13 more
St. Jude Children's Research Hospital 48
Not applicableUnknownNCT06050057
What this trial is testing

Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy

Who this might be right for
Adrenal TumorAdrenal DiseaseAdrenal Mass+10 more
University Hospital Olomouc 100
Testing effectiveness (Phase 2)Ended earlyNCT04187404
What this trial is testing

A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma

Who this might be right for
Adrenocortical CarcinomaPheochromocytomaParaganglioma
Enterome 70
Testing effectiveness (Phase 2)Study completedNCT00324012
What this trial is testing

Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Rigshospitalet, Denmark 19
Not applicableStudy completedNCT05344027
What this trial is testing

The Impact of Mitotane Therapy on Serum Free Proteins in Patients With Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
King's College Hospital NHS Trust 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT03604198
What this trial is testing

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

Who this might be right for
Cushing Syndrome
Corcept Therapeutics 125
Next Page